Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schweizer, A.
Right arrow Articles by Licker, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schweizer, A.
Right arrow Articles by Licker, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, Vol 84, Issue 1 16-22, Copyright © 2000 by Oxford University Press

ARTICLES

Aprotinin does not impair renal haemodynamics and function after cardiac surgery

A Schweizer, L Hohn, DR Morel, A Kalangos and M Licker
Division of Anaesthesiology, Hopital Cantonal Universitaire, Geneve, Switzerland.

Patients undergoing cardiac surgery with moderate hypothermic cardiopulmonary bypass (CPB) were allocated randomly to receive either saline (control group, n = 29) or a high-dose regimen of aprotinin (aprotinin group, n = 28). In both groups, CPB was associated with similar and transient increases in effective renal plasma flow (+54% in controls and +48% in aprotinin-treated patients) and in fractional excretion of sodium and potassium, but glomerular filtration rate remained unchanged. Plasma and urinary ratios of 6-keto-PGF1 alpha to thromboxane B2 (TxB2) increased significantly, indicating systemic and renal release of vasodilatory prostaglandins. Osmolar clearance correlated with urinary excretion of cyclic GMP (r = 0.79 and 0.86 in the control and aprotinin groups, respectively) and 6-keto-PGF1 alpha (r = 0.63 and 0.69 in the control and aprotinin groups, respectively). Compared with preoperative values, plasma atrial natriuretic peptide increased after weaning from CPB (+71% and +93% in the control and aprotinin groups, respectively). Aprotinin had no apparent adverse effect on renal function and it did not alter mechanisms involving prostanoids and atrial natriuretic peptide during cardiac surgery.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
D. L. Ngaage, A. R. Cale, M. E. Cowen, S. Griffin, and L. Guvendik
Aprotinin in Primary Cardiac Surgery: Operative Outcome of Propensity Score-Matched Study
Ann. Thorac. Surg., October 1, 2008; 86(4): 1195 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
B. G. Loef, R. H. Henning, G. Navis, A. J. Rankin, W. van Oeveren, T. Ebels, and A. H. Epema
Changes in glomerular filtration rate after cardiac surgery with cardiopulmonary bypass in patients with mild preoperative renal dysfunction
Br. J. Anaesth., June 1, 2008; 100(6): 759 - 764.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. D. McEvoy, S. T. Reeves, J. G. Reves, and F. G. Spinale
Aprotinin in Cardiac Surgery: A Review of Conventional and Novel Mechanisms of Action
Anesth. Analg., October 1, 2007; 105(4): 949 - 962.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. R. Brown, N. J.O. Birkmeyer, and G. T. O'Connor
Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery
Circulation, June 5, 2007; 115(22): 2801 - 2813.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. J. Rodrigues, P. R. B. Evora, S. Bassetto, P. M. Luciano, L. Alves Jr, A. S. Filho, and W. V. de Andrade Vicente
Efficacy and Safety of Aprotinin Use for Reoperative Valvular Surgery
Ann. Thorac. Surg., June 1, 2007; 83(6): 2060 - 2065.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. C. Body and C. D. Mazer
Pro: Aprotinin Has a Good Efficacy and Safety Profile Relative to Other Alternatives for Prevention of Bleeding in Cardiac Surgery
Anesth. Analg., December 1, 2006; 103(6): 1354 - 1359.
[Full Text] [PDF]

Home page
 NEJMHome page
D. T. Mangano, I. C. Tudor, C. Dietzel, and the Multicenter Study of Perioperative Ischemia Re
The Risk Associated with Aprotinin in Cardiac Surgery
N. Engl. J. Med., January 26, 2006; 354(4): 353 - 365.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. H. Kincaid, D. A. Ashburn, J. R. Hoyle, M. G. Reichert, J. W. Hammon, and N. D. Kon
Does the Combination of Aprotinin and Angiotensin-Converting Enzyme Inhibitor Cause Renal Failure After Cardiac Surgery?
Ann. Thorac. Surg., October 1, 2005; 80(4): 1388 - 1393.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
A. M. Mahdy and N. R. Webster
Perioperative systemic haemostatic agents
Br. J. Anaesth., December 1, 2004; 93(6): 842 - 858.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
G. Brancaccio, G. Michielon, R. M Di Donato, D. Costa, F. Falzea, and F. Miraldi
Atrial natriuretic factor in normothermic and hypothermic cardiopulmonary bypass
Perfusion, May 1, 2004; 19(3): 157 - 162.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. P. Taggart, V. Djapardy, M. Naik, and A. Davies
A randomized trial of aprotinin (Trasylol) on blood loss, blood product requirement, and myocardial injury in total arterial grafting
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1087 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
J. M. Karski and J. T. Balatbat
Blood Conservation Strategies in Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2003; 7(2): 175 - 188.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.